Christopher J. Giuliano

1.7k total citations · 1 hit paper
12 papers, 920 citations indexed

About

Christopher J. Giuliano is a scholar working on Molecular Biology, Epidemiology and Parasitology. According to data from OpenAlex, Christopher J. Giuliano has authored 12 papers receiving a total of 920 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Epidemiology and 4 papers in Parasitology. Recurrent topics in Christopher J. Giuliano's work include CRISPR and Genetic Engineering (5 papers), Toxoplasma gondii Research Studies (4 papers) and Cytomegalovirus and herpesvirus research (3 papers). Christopher J. Giuliano is often cited by papers focused on CRISPR and Genetic Engineering (5 papers), Toxoplasma gondii Research Studies (4 papers) and Cytomegalovirus and herpesvirus research (3 papers). Christopher J. Giuliano collaborates with scholars based in United States, Italy and Canada. Christopher J. Giuliano's co-authors include Ann Lin, Jason M. Sheltzer, Ann Palladino, Kristen M. John, Luwei Liu, Alexander R. Chait, Clara Tucker, Erin L. Sausville, Nicole M. Sayles and Steven E. Glynn and has published in prestigious journals such as Science, SHILAP Revista de lepidopterología and Molecular Cell.

In The Last Decade

Christopher J. Giuliano

11 papers receiving 907 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials

2019 455 citations Ann Lin, Christopher J. Giuliano et al. Science Translational Medicine profile →

Peers

Countries citing papers authored by Christopher J. Giuliano

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Giuliano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Giuliano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Giuliano more than expected).

Fields of papers citing papers by Christopher J. Giuliano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Giuliano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Giuliano. The network helps show where Christopher J. Giuliano may publish in the future.

Co-authorship network of co-authors of Christopher J. Giuliano

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Giuliano. A scholar is included among the top collaborators of Christopher J. Giuliano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Giuliano. Christopher J. Giuliano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Alternative start codon selection shapes mitochondrial function and rare human diseases 2025 ·Molecular Cell ·Jimmy Ly, (unknown), (unknown), (unknown), Christopher J. Giuliano, Sebastian Lourido, Mark D. Fleming, Iain M. Cheeseman	0
2	Immune targeting and host-protective effects of the latent stage of Toxoplasma gondii 2025 ·Nature Microbiology ·(unknown), (unknown), (unknown), Sambamurthy Chandrasekaran, Christopher J. Giuliano, (unknown), Elinor Willis, Christoph Konradt, David A. Christian, Daniel L. Aldridge, (unknown), Maxime Jacquet, Florence Dzierszinski, Eleni Katifori, Sebastian Lourido, Anita A. Koshy, Christopher A. Hunter	1
3	CRISPR-based functional profiling of the Toxoplasma gondii genome during acute murine infection 2024 ·Nature Microbiology ·Christopher J. Giuliano, (unknown), (unknown), Benjamin S. Waldman, (unknown), Elizabeth A. Boydston, Tammy C. T. Lan, (unknown), (unknown), (unknown), Isabelle Coppens, Jeffrey D. Dvorin, Sebastian Lourido	13
4	TgATG9 is required for autophagosome biogenesis and maintenance of chronic infection in Toxoplasma gondii 2024 ·SHILAP Revista de lepidopterología ·(unknown), Zhihai Zhang, (unknown), Feng‐Rong Wang, (unknown), Christopher J. Giuliano, Sebastian Lourido, Manlio Di Cristina, Daniel J. Klionsky, Vern B. Carruthers	2
5	A positive feedback loop controls Toxoplasma chronic differentiation 2023 ·Nature Microbiology ·(unknown), Christopher J. Giuliano, (unknown), (unknown), (unknown), (unknown), Sambamurthy Chandrasekaran, Benjamin S. Waldman, Anita A. Koshy, Christopher A. Hunter, Sebastian Lourido	22
6	Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials breakdown → 2019 ·Science Translational Medicine ·Ann Lin, Christopher J. Giuliano, Ann Palladino, Kristen M. John, (unknown), (unknown), Erin L. Sausville, (unknown), Luwei Liu, Alexander R. Chait, (unknown), Clara Tucker, Jason M. Sheltzer	455
7	FABP1 controls hepatic transport and biotransformation of Δ9-THC 2019 ·Scientific Reports ·Matthew W. Elmes, (unknown), Luke L. McGoldrick, Christopher J. Giuliano, Joseph Sweeney, (unknown), (unknown), Gregory Carbonetti, Keith M. Studholme, Dale G. Deutsch, Robert C. Rizzo, Steven E. Glynn, Martin Kaczocha	23
8	Generating Single Cell–Derived Knockout Clones in Mammalian Cells with CRISPR/Cas9 2019 ·Current Protocols in Molecular Biology ·Christopher J. Giuliano, Ann Lin, Vishruth Girish, Jason M. Sheltzer	76
9	MELK expression correlates with tumor mitotic activity but is not required for cancer growth 2018 ·eLife ·Christopher J. Giuliano, Ann Lin, Joan C. Smith, Ann Palladino, Jason M. Sheltzer	61
10	Abstract 837A: Combining CRISPR/Cas9 mutagenesis and a small-molecule inhibitor to probe the function of MELK in cancer 2018 ·Cancer Research ·Christopher J. Giuliano, Ann Lin, Joan C. Smith, Ann Palladino, Jason M. Sheltzer	1
11	Structure of the mitochondrial inner membrane AAA+ protease YME1 gives insight into substrate processing 2017 ·Science ·Cristina Puchades, Anthony J. Rampello, Mia Shin, Christopher J. Giuliano, R. Luke Wiseman, Steven E. Glynn, Gabriel C. Lander	159
12	CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials 2017 ·eLife ·Ann Lin, Christopher J. Giuliano, Nicole M. Sayles, Jason M. Sheltzer	107

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact